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DObjective:Current guidelines have recommended against coronary revascularization before noncardiac surgery
in patients with asymptomatic coronary artery disease. However, myocardial infarction after thoracic aneurysm
(TA) repair dramatically increases the morbidity and mortality. Revascularization with coronary artery bypass
grafting before TA repair minimizes the incidence of perioperative ischemia. However, the recovery can be
prolonged, and a percentage of patients will either never return for aneurysm repair or will develop a rupture
during convalescence. Percutaneous coronary intervention (PCI) before TA repair might be preferable.
Previous studies examining PCI before major vascular surgery included few patients with TAs. We examined
the outcomes of patients undergoing PCI before TA repair.
Methods: From 1997 to 2012, 592 patients underwent TA repair. Patients presenting for elective repair
underwent cardiac catheterization before surgery. Thosewith significant single- or double-vessel coronary artery
disease underwent PCI. The perioperative outcomes were examined and compared with those of patients
undergoing TA repair without revascularization.
Results: A total of 44 patients (7.4%) underwent PCI with bare metal stents before surgery. No PCI-related
complications occurred. Dual antiplatelet therapy was administered for 4 to 6 weeks. No instances of aneurysm
rupture occurred in the interval between PCI and surgery. The incidence of stent thrombosis, myocardial
infarction, and mortality for those undergoing PCI was 0. No bleeding complications occurred.
Conclusions: PCI is safe and efficacious in patients undergoing TA repair. Aneurysm rupture did not occur
in the interval before surgery. Antiplatelet therapy did not increase the risk of bleeding complications. Stent
thrombosis was not seen. We recommend PCI those with significant single- or double-vessel coronary artery
disease before elective TA repair. (J Thorac Cardiovasc Surg 2014;147:163-8)According to the current guidelines from the American
College of Cardiology and the American Heart Association
(ACC/AHA), coronary revascularization before elective
noncardiac surgery is not recommended.1 The results of
randomized, controlled trials have failed to demonstrate a
reduction in the incidence of perioperative myocardial
infarction (MI) or an improvement in long-term survival
when percutaneous coronary intervention (PCI) was
performed before major vascular surgery, including
abdominal aortic aneurysm (AAA) repair.2,3 Despite
these recommendations, however, controversy has
persisted regarding the benefits of preoperative myocardiale Department of Cardiothoracic Surgery, Weill Cornell Medical College,
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The Journal of Thoracic and Carevascularization in a higher risk cohort of patients
undergoing major vascular surgery.2,4 In particular,
those undergoing aortic reconstruction are a particularly
high-risk group with a significantly increased incidence of
lethal perioperative MI.4 When revascularization precedes
surgery in these higher risk cohorts, patients derive not
only a reduction in their perioperative mortality, but also
improvement in their long-term survival.5
Patients undergoing either descending thoracic aneurysm
(DTA) or thoracoabdominal aortic aneurysm (TAAA)
repair constitute an even higher risk cohort requiring major
vascular surgery. Proximal aortic crossclamping, blood
loss, and rapid volume shifts create greater degrees of
myocardial work, increasing the risk of significant
myocardial ischemia. Such dramatic shifts in the hemo-
dynamics increase intracoronary wall shear stress and can
precipitate endothelial damage, vulnerable plaque rupture,
and acute MI.6,7 In patients undergoing emergent
aneurysm repair for thoracic aortic rupture, the increased
risk of perioperative ischemia was evident in the 100%
mortality seen in patients experiencing a MI either during
or after repair of their ruptured aneurysm.8 Before the
present experience, we had adopted a strategy of cardiac
catheterization before elective TA repair. Those withrdiovascular Surgery c Volume 147, Number 1 163
Abbreviations and Acronyms
AAA ¼ abdominal aortic aneurysm
ACC/AHA ¼ American College of Cardiology and
the American Heart Association
CABG ¼ coronary artery bypass grafting
CAD ¼ coronary artery disease
DTA ¼ descending thoracic aneurysm
MI ¼ myocardial infarction
PCI ¼ percutaneous coronary intervention
TAAA ¼ thoracoabdominal aortic aneurysm
TA ¼ thoracic aneurysm
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Dsignificant coronary artery disease (CAD) underwent
preoperative myocardial revascularization with either
coronary artery bypass grafting (CABG) or PCI. Although
wewere content with our results with these patients, a report
of catastrophic stent thrombosis in patients undergoing PCI
before thoracoabdominal aneurysm repair stimulated us to
examine our practice in more detail.9 The possibility of
aneurysm rupture during the post-PCI period was also of
concern. We sought to examine the safety and efficacy of
PCI before elective, open repair of aneurysms of the
thoracoabdominal or descending thoracic aorta.
METHODS
Patients
A retrospective review of the department of cardiothoracic surgery
aortic surgery database was conducted to identify patients who had
undergone either DTA or TAAA repair from July 1997 to July 2012.
The institutional review board approved the study and waived the need
for individual patient consent.
During the study period, a total of 592 cases were performed: 407
TAAA and 185 DTA. Of the 592 cases, 87 patients presented with aortic
rupture and an additional 33 presented with acute aortic syndromes that
required urgent intervention negating a full cardiac evaluation before
surgery. These 120 patients were excluded from the present analysis,
leaving 472 patients with a cardiac evaluation before surgery available.
Preoperative Cardiac Evaluation
Of the 472 patients, 28 (5.9%) were<40 years oldwith a known connec-
tive tissue disorder and normal or mildly reduced left ventricular function.
These patients underwent nuclear stress imaging. No evidencewas found of
ischemia on any of these examinations, and cardiac catheterization was not
performed. The remaining 444 patients underwent cardiac catheterization
before TA repair. Patients identified with severe left main CAD (n ¼ 9)
and those with significant triple-vessel CAD (n ¼ 22) underwent CABG
(n ¼ 31, 6.6%) before aneurysm repair. An additional 44 patients (9.3%)
were identified with either significant (>70% stenosis) single- or double-
vessel disease and were referred for PCI either during the initial angiogram
or the following day. The demographics and cardiac risk factors of the
patients undergoing PCI are listed in Table 1. Patients undergoing PCI
had a significantly greater mean aneurysm diameter than those not
undergoing preoperative revascularization (8.3 cm vs 6.9 cm; P<.001).
Percutaneous Coronary Intervention
All patients undergoing PCI were treated with bare metal stents.
Their angina status before PCI are listed in Table 2. None of the patients164 The Journal of Thoracic and Cardiovascular Surgpresented with acute MI. Most (86%) required only single-vessel
intervention; 14% needed double-vessel PCI. Before stent insertion, the
patients were given a loading dose of 300 mg of clopidogrel. Double
antiplatelet therapy (75 mg clopidogrel and 81 mg aspirin) was continued
for a mean of 4.6 weeks (range, 3.3-8) in this study group. Clopidogrel was
discontinued 1 week before the patient’s planned aortic reconstruction.
Aspirin was continued until the day before surgery and was resumed after
spinal drain removal.
Anesthesia, Surgical Procedures, and Postoperative
Care
General anesthesia was induced with intravenous midazolam
hydrochloride and sodium pentothal or propofol, followed by fentanyl
citrate boluses. Paralysis was maintained using vecuronium bromide. All
patients received invasive hemodynamic monitoring with an arterial line
and right heart catheter. Single lung ventilation was achieved with a
bronchial blocker. A spinal drain was inserted between the fourth and
fifth lumber vertebrae, and the intrathecal pressure was maintained
at <12 mm Hg throughout the procedure and for the first 72 hours
postoperatively (maximum, 25 mL of spinal fluid drained per hour).
A fifth intercostal space thoracotomy or thoracoabdominal incision was
used in all patients. For those undergoing surgery with either a clamp and
sew technique or the assistance of left heart bypass, 100 IU/kg of heparin
was administered, with subsequent boluses given to maintain an activated
clotting time>300 seconds. The core temperature was allowed to decrease
to 33C before crossclamping. Left heart bypass was used for those patients
with compromised left ventricular function (ejection fraction>40%), all
extent II aneurysms, and those with chronic dissection. The flow was
maintained at 3 L/min. Aggressive red blood cell salvagewas used to return
lost blood volume. When proximal aortic control was unattainable,
circulatory arrest was used. For circulatory arrest, 400 IU/kg of heparin
was given, femoral vein to femoral artery cardiopulmonary bypass was
initiated, and the patients were cooled to a core temperature of 18C.
Rewarming was achieved, maintaining a blood temperature to core
temperature gradient of 10C.
Aortic reconstruction was performed with Hemashield Dacron grafts
(Macquet Corp, Oakland, NJ). After completion of the procedure,
protamine sulfate was administered to reverse the anticoagulation, and
blood products were administered as necessary to reverse the coagulopathy.
In the intensive care unit, the mean arterial pressure was maintained at
>85 mm Hg for the first 72 hours postoperatively. Inotropes were added
as indicated. The spinal drain was removed on postoperative day 3.
All patients were assessed for myocardial ischemia with serial
electrocardiographic monitoring. Those who had undergone previous
PCI or CABG and those with known moderate CAD were also evaluated
with serial serum cardiac enzyme analysis. A new MI was defined as
new Q waves or ST-segment elevation on the electrocardiogram or by a
troponin I level>0.04 mg/mL.
Statistical Analysis
All the data collected from 1997 to 2012 were stored using Microsoft
Access (2010) software (Microsoft, Redmond, Wash). Processing and
analysis of the data were performed using IBM SPSS Statistics, version 20
(IBM, Armonk, NY). The chi-square test and Student’s t test were used.
P  .05 was considered statistically significant.RESULTS
A total of 44 patients underwent PCI before repair of
their TA. The stented vessels are listed in Table 2. No
myocardial, cerebrovascular, or access complications
occurred related to either diagnostic angiography or PCI.
No postintervention MIs occurred, and all patientsery c January 2014
TABLE 1. Preoperative patient demographics
Variable Value
Total 44
Female gender 32 (73)
Age (y)
Mean 72.6
Range 38-92
Ejection fraction (%)
Mean 47
Range 20-60
Mean aneurysm diameter (cm) 8.3  1.3
NYHA class
I 36 (82)
II 4 (9)
III 1 (2)
IV 3 (7)
CAD risk factors
Smoking 28 (63)
Hyperlipidemia 11 (25)
Diabetes mellitus 6 (14)
Hypertension 44 (100)
Family history of CAD 5 (11)
Data presented as n (%), unless otherwise noted. NYHA, New York Heart
Association; CAD, coronary artery disease.
TABLE 3. Aneurysm type, operative technique, and in-hospital
morbidity and mortality
Variable Patients (n)
Aneurysm type
Extent I TAAA 15 (34)
Extent II TAAA 6 (14)
Extent III TAAA 8 (18)
Extent IV TAAA 2 (4)
DTA 13 (30)
Operative technique
Clamp and sew 34 (77)
Left heart bypass 9 (20)
Circulatory arrest 1 (3)
Morbidity and mortality
MI 0
CVA 1 (2)
SCI 1 (2)
Return to OR for bleeding 0
Acute renal failure or HD 2 (4.5)
Tracheostomy 2 (5)
Mortality 0
Data in parentheses are percentages. TAAA, Thoracoabdominal aneurysm;
DTA, descending thoracic aneurysm; MI, myocardial infarction; CVA, cerebro-
vascular accident; SCI, spinal cord injury; OR, operating room; HD, hemodialysis.
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All 44 patients returned within 8 weeks for their aneurysm
repair. No patient experienced aneurysm rupture in the
interval between PCI and surgery.
An additional 31 patients underwent CABG before their
TAAA repair. No perioperative strokes or mortalities
occurred related to that procedure. No aneurysm rupture
occurred in the interim between CABG and aneurysm
repair, although the mean interval between the 2 procedures
was 3 months. After TAAA repair, no MIs occurred and no
graft occlusion was evident in the perioperative period.
The operative procedures, techniques, and postoperative
complications of the study cohort are listed in Table 3. Of
the 31 patients undergoing TAAA repair, 21 (68%) had
Crawford extent I and II aneurysms. Of the 13 patients
undergoing DTA repair, 8 (61%) required replacement ofTABLE 2. Anginal status and PCI target vessels
Variable Patients (n)
Anginal status at presentation
Asymptomatic 36 (81)
Stable angina 4 (9)
Unstable angina 4 (9)
Acute MI 0 (0)
Coronary artery stented
LAD 12 (27)
Circumflex 15 (34)
RCA 11 (25)
RCA and circumflex 6 (14)
Data in parentheses are percentages. PCI, Percutaneous coronary intervention;
MI, myocardial infarction; LAD, left anterior descending; RCA, right coronary artery.
The Journal of Thoracic and Catheir entire descending aorta. Of the 44 patients, 34
(77%) had their aneurysms repaired using a clamp and
sew technique. The remainder underwent repair with the
assistance of left heart bypass (n ¼ 9, 20%) or circulatory
arrest (n ¼ 1, 3%).
No perioperative MIs or instances of stent thrombosis
occurred. No patient required a return to the operating room
for postoperative hemorrhage. The 1 patient experiencing a
cerebrovascular accident (2.3%) recovered completely
without deficit before discharge.The1patientwith paraplegia
after surgery (2.3%) had had an extent IVaneurysm repaired
with a clamp and sew technique and a crossclamp time of 30
minutes. He has remained paralyzed. Two patients (4.5%)
required tracheostomy after prolonged intubation. Two pa-
tients (4.5%) requiring renal replacement therapy after aneu-
rysm repair recovered their renal function before discharge.
No 30-day or in-hospital mortality occurred among the
44 patients undergoing PCI before aneurysm repair.
Univariate analysis comparing elective patients undergo-
ing preoperative PCI (group 1) and those undergoing either
preoperative CABG (group 2) or no revascularization (group
3) failed to demonstrate a significant difference among the
groups with respect to mortality (P<.33), MI (P<1.0), or
spinal cord injury (P<.7). Those undergoing PCI did have
a significantly greater incidence of cerebrovascular accident
compared with group 3 (no revascularization; P<.027).DISCUSSION
The most recent ACC/AHA guidelines for perioperative
cardiovascular evaluation and care for the noncardiacrdiovascular Surgery c Volume 147, Number 1 165
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Dsurgery patient were published in 2007.1 Based on extensive
review of the published data, these recommendations
guide the need for preoperative cardiac evaluation and
revascularization according to the patient’s symptoms
and/or the presence of threatening obstructive CAD.
Specific references are made to the patient undergoing
major vascular surgery, including those requiring AAA
repair, because 50% of these patients have been shown
to have significant CAD.10 In symptomatic patients with
known left main or triple vessel disease, revascularization
before surgery has been strongly recommended. Similar
class I, level of evidence A recommendations have been
made for patients meeting the following criteria: symptoms
with 2-vessel disease involving the proximal left
anterior descending artery, symptoms with an ejection
fraction < 50%, or ischemia on stress testing. Patients
with angina who require elective surgery within the next
12 months, such as the 19% of patients in our study, should
undergo PCI, if possible, followed by 4 to 6 weeks of dual
antiplatelet therapy before proceeding. However, 81% of
the patients in our series were asymptomatic with respect
to their CAD. The current guidelines have recommended
against preoperative invasive testing and revascularization.
These class III, level of evidence B recommendations
suggest that this cohort of patients will not only fail to
benefit from preoperative revascularization, but also might
actually be harmed during either the evaluation or treatment
of CAD before surgery.
The AHA/ACC guidelines were developed after
randomized, prospective trials failed to show a benefit for
coronary revascularization in patients needing major
vascular surgery. In 2004, the Coronary Artery Revascular-
ization Prophylaxis trial reported on 510 patients in need of
vascular surgery, one half of whom were randomized to
coronary revascularization before their procedure.3 Despite
preoperative PCI or CABG, 12% of these patients experi-
enced aMI after surgery and 14%without revascularization
had a similar outcome. At a median follow-up of 2.7 years,
no significant difference was found in survival (22% vs
23%). However, this highly selected group of patients
excluded those with left main disease or a reduced ejection
fraction. In addition, only one third of the patients had
undergone AAA repair, a population that has been shown
to have a significantly greater risk than those undergoing
infrainguinal vascular reconstruction.4 When analyzing
those higher risk patients undergoing AAA repair, a
significantly greater incidence of MI after surgery (19%
vs 7.5%, P ¼ .01) was found. The short- and long-term
mortality for the patients with an AAAwas not reported.
A second randomized study, the Decrease-V pilot study,
also randomly assigned preoperative revascularization to
101 patients scheduled for major vascular surgery.2 Again,
fewer than one third of the patients were in the high-risk
category undergoing AAA repair. Despite a trend toward166 The Journal of Thoracic and Cardiovascular Surga greater composite endpoint of all-cause mortality or
MI at 30 days (43% vs 33%, P ¼ .3), the investigators
concluded that preoperative revascularization was
not associated with improved outcomes. Despite the
acknowledgement that the study had been severely
underpowered, these data, and the data from the Coronary
Artery Revascularization Prophylaxis, were highly
influential in the development of the AHA/ACC guidelines.
Examining a higher risk cohort of patients, Monaco and
colleagues5 reported on 208 consecutive moderate- to
high-risk patients scheduled for elective major vascular
surgery. The patients were randomized to either selective
coronary angiography because of positive noninvasive
testing findings or routine systematic preoperative coronary
angiography. Of the 103 patients in the selective group, 46
subsequently underwent cardiac catheterization, with most
requiring either PCI or CABG before their vascular surgery.
No perioperative MIs or mortalities occurred in that group.
Of the remaining 57 patients not undergoing catheterization
because of negative stress imaging findings, the mortality
was 6.5%, with all deaths from cardiac causes. In those
undergoing mandatory catheterization before high-risk
vascular surgery, 60% required revascularization. Again,
no perioperative MIs or mortalities occurred in that group.
Furthermore, in the group undergoing mandatory
catheterization, a 53.6% relative risk reduction from any
cardiac-related events out to 8 years was found. These
same patients also benefitted from a 16.7% absolute
reduction in all-cause mortality out to 4 years compared
with those patients undergoing selective angiography only.
Patients undergoing DTA and TAAA repair are clearly a
higher risk cohort than even those undergoing AAA repair.
Proximal aortic crossclamping generates rapid increases in
the left ventricular systolic and diastolic dimensions,
myocardial wall stress, mean arterial pressure, and heart
rate.11 Such dramatic hemodynamic changes can
precipitate acute MI by increasing intracoronary wall
shear stress, endothelial damage, and vulnerable
plaque rupture.6,7 The importance of maximizing the
perioperative cardiac function, including the prevention
of MI, is highlighted when examining the role of
perioperative cardiac complications on outcomes in
patients undergoing major thoracic aortic reconstruction.
In a contemporary report of 509 patients undergoing
elective TAAA repair, Wong and colleagues12 reported
that 26.7% of their patients had a cardiac complication after
surgery. These patients had a 25.7% mortality rate
compared with 1.3% mortality in those who did not.12 In
patients undergoing emergent repair of ruptured DTA or
TAAAs, the influence of perioperative ischemia will be
even more pronounced. Nearly 60% of the mortalities in
our experience were secondary to an acute MI, and all
4 patients experiencing an MI died either in the operating
room or within 48 hours in the intensive care unit.8ery c January 2014
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DA reduction in the incidence of MI will not only reduce the
mortality but has also been shown to reduce the risk of
spinal cord dysfunction after thoracoabdominal aneurysm
repair.13
Two additional concerns for patients undergoing PCI
before major vascular surgery are the potential for stent
thrombosis in the perioperative period and aneurysm
rupture in the interim between revascularization and
surgery. An earlier report by Kaluza and colleagues9
detailed catastrophic stent thrombosis in patients under-
going vascular surgery, including TAAA repair, within 2
weeks of bare metal stent placement. Of 40 patients in their
series, 7 sustained a perioperative MI secondary to stent
thrombosis. Of the 7MIs, 6 (86%) were fatal, with 1 patient
surviving after emergent angioplasty. Amore contemporary
and larger experience with this same cohort of patients
showed similarly fatal outcomes, with 75% mortality in
those experiencing stent thrombosis after noncardiac
surgery.14 However, a more detailed analysis of these data
showed that none of the events occurred when the patients
had been treated for 6 weeks with dual antiplatelet therapy
before proceeding to surgery. Stent placement results
in denudation of the coronary artery endothelium.
Re-endothelialization occurs within 8 weeks of PCI and
even 2 weeks of therapy with a thienopyridine, such as
clopidogrel, substantially reduces the risk of acute stent
thrombosis.15,16 The safety of percutaneous coronary
revascularization is epitomized in our series. None of
the patients experienced a complication related to
angiography or stent placement. After a mean delay of
4.6 weeks after PCI, clopidogrel was stopped and aspirin
therapy was continued throughout the perioperative
period. Not a single incident of perioperative stent
thrombosis or MI was seen in the patients receiving this
form of therapy before DTA or TAAA repair. Just as
important, no instances of aneurysm rupture occurred
while waiting for stent endothelialization.
The results of the present study support an aggressive
approach to treating CAD before DTA or TAAA repair.
Preoperative coronary angiography and PCI with bare metal
stents is safe. Delaying surgery for 4 to 6 weeks will allow
the stents to endothelialize and will not increase the risk of
aneurysm rupture. Despite the hypercoagulable state often
seen in the period after aneurysm repair,17 PCI protected
patients against MI, a highly mortal event after elective
and emergent TA repair. In addition, dual antiplatelet
therapy did not result in an increase in perioperative
bleeding complications.
The limitations of the present study included the
small sample size and the retrospective nature of our
investigation. In addition, no contemporary comparative
study cohort was available to evaluate cardiac complica-
tions and their influence on outcomes in patientsThe Journal of Thoracic and Caundergoing high-risk, open TA repair without treatment of
known, significant CAD.
CONCLUSIONS
Patients undergoing elective TA repair have a significant
incidence of silent CAD. Perioperative MI substantially
increases the morbidity and mortality of these operations.
The incidence of these events can be dramatically reduced
in patients with single- or double-vessel CAD by
performing PCI before aneurysm repair. Although these
data were from a small cohort of nonrandomized
patients, consideration should be given to modifying the
ACC/AHA guidelines to reflect the safety and efficacy of
PCI before elective TA repair.
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Dr Anthony L. Estrera (Houston, Tex). Very nice and clear
presentation, Len.
The ACC and AHA have provided us with guidelines for
invasive testing for CAD before noncardiac major vascular
surgery based primarily on clinical status; that is, the presence
of symptoms and the functional status, as represented bymetabolic
equivalents or METS, and have recommended coronary artery
intervention for patients with a reduced ejection fraction and
multivessel disease and those with left main disease.
This was based on level 1 data from randomized trials, as you
had mentioned, on major vascular surgery, albeit, few or no
patients were included with TAAAs.
Dr Girardi has adopted a policy to perform cardiac
catheterization for most of these patients before TAAA repair,
and that 1- or 2-vessel disease, if discovered, should receive
intervention with PCI using a bare metal stent.
You demonstrated excellent results in this group of 44 patients,
with no postoperative MI, no stent thrombosis, no bleeding, and no
death. However, I am still concerned about opposing the guidelines
of the AHA and ACC.
I have 2 questions. First, as suggested in your protocol, most
patients underwent cardiac catheterization before TAAA repair.
With concern for postoperative renal failure, although you had a
low percentage of it, what was the interval between heart
catheterization and repair, and what is your current policy
regarding this?
Dr Girardi. In the patients who are coming in for elective
repair, just as for any other aneurysm repair, we will perform
catheterization the day before. However, we ask for only a
coronary angiogram and a right heart catheterization. We do not
perform a formal aortogram or a V-gram. We try to keep the
contrast to a minimum, and we have not found that to be a problem
contributing to renal failure postoperatively.
Thus, in most of the patients, we will perform catheterization
the day before just as if they were going to undergo valve surgery
or coronary bypass.
Dr Estrera. Second question. In a report from our group, we
suggested that patients with normal functional capacity and a
normal left ventricular ejection fraction did not require additional
workup, just as has been suggested by the ACC and AHA. In your
study, 82% of the study cohort were asymptomatic and would not
have normally undergone an invasive evaluation.168 The Journal of Thoracic and Cardiovascular SurgWithout a true control group, how do you really know that these
patients would not have done well without PCI, and should this
have tempered your conclusions?
Dr Girardi. Well, certainly I think 1 of the reasons that we
started studying this was exactly as you had stated, our
concern for actually going against the recommendations of the
AHA/ACC guidelines.
Now, the IIIb recommendations are pretty strong, especially
when they start talking about the potential harm associated with
the procedure or with PCI itself. We wanted to ensure that, at
the very minimum, we were not hurting anybody, and I think we
have shown that we have not. We have not hurt these patients
with the procedure itself. We also have not hurt them with
complications from the stenting.
The only point that we can use to state that we are really
providing patients with a benefit is when you consider the
historical controls of TA repair, and the incidence of MI, although
not crazy, is still pretty high, 5% or 6%. Also, if the patients
develop these complications, it has been a strong predictor for a
bad outcome. For those patients who we took to the operating
room emergently who did experience a MI, the MIs were almost
all uniformly fatal.
The stresses of TA repair as far as the hemodynamics, as far as
the cardiac work and the amount of ischemia generated is far
different than what we will see in patients undergoing peripheral
vascular surgery, from whom most of these data were generated.
Thus, we think it is justified. Certainly, if we can do better at
protecting them from a potentially fatal complication such as
MI, we think it is worthwhile.
Dr Estrera. Nice job, Len.
DrMarcR.Moon (St Louis, Mo). It was not clear to me, but did
you have any functional analysis that could have, potentially—for
example, stress tests—that could have ruled out most of the
patients so that you did not have to perform catheterization on
everybody?
Dr Girardi.We did not perform stress tests for all the patients.
We were very aggressive with catheterization.
One of the concerns in that situation is the patients who have left
main disease, which constituted about 7% of the patients who
eventually underwent CABG. Most of those were patients with
left main disease. As you know, the stress test often will not detect
left main disease because of balanced ischemia.
We have been relying less on nuclear stress imaging and more
on computed tomographic angiography currently to study the
coronary arteries. In those patients for whom we have a low index
of suspicion for CAD, we have mostly used cardiac computed
tomographic angiography rather than even performing a stress test.
Dr Moon. That is 1 approach. We do perform stress tests for
everybody, using an adenosine thallium nuclear test or dobutamine
echocardiography. If those tests have negative findings, we do not
perform catheterization. However, that is a different approach.ery c January 2014
